0
Puma Biotechnology Inc
- 51-200 Employees
- Based in Los Angeles, California
Puma Biotechnology, Inc., a development stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of products for the treatment of various forms of cancer. Its drug candidates include PB272 (neratinib (oral)) for the treatment of advanced breast cancer patients, non-small cell lung cancer patients, and patients with HER2 mutation-positive solid tumors…More
Puma Biotechnology Inc
Most Recent Responsibility Report
MOST RECENT
Request Information
Puma Biotechnology Inc does not currently have any reports on ResponsibilityReports.co.uk. Click the button below to be notified when financial info becomes available.
Our service enables potential investors to review the most recent and archived Puma Biotechnology Inc Sustainability Report, Puma Biotechnology Inc Corporate Social Responsibility Report, Puma Biotechnology Inc CSR Report, Puma Biotechnology Inc Corporate Responsibility, Puma Biotechnology Inc CR Report, Puma Biotechnology Inc Citizenship Report, Puma Biotechnology Inc ESG Report, and Puma Biotechnology Inc Environmental Report online.